Transcription Factor YY1 Contributes to Tumor Growth by Stabilizing Hypoxia Factor HIF-1α in a p53-Independent Manner

Abstract

In response to hypoxic stress, hypoxia-inducible factor (HIF)-1a is a critical transcription factor regulating fundamental cellular processes, and its elevated expression level and activity are associated with poor outcomes in most malignancies. The transcription factor Yin Yang 1 (YY1) is an important negative regulator of the tumor suppressor factor p53. However, the role of YY1 under tumor hypoxic condition is poorly understood. Herein, we show that inhibition of YY1 reduced the accumulation of HIF-1a and its activity under hypoxic condition, and consequently downregulated the expression of HIF-1a target genes. Interestingly, our results revealed that the downregulation of HIF-1a by inhibiting YY1 is p53-independent. Functionally, the in vivo experiments revealed that inhibition of YY1 significantly suppressed growth of metastatic cancer cells and lung colonization and also attenuated angiogenesis in a p53-null tumor. Collectively, our findings unraveled a novel mechanism by which YY1 inhibition disrupts hypoxia-stimulated HIF-1a stabilization in a p53-independent manner. Therefore, YY1 inhibition could be considered as a potential tumor therapeutic strategy to give consistent clinical outcomes independent of p53 status. Cancer Res; 73(6);

PRMT7 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Breast Cancer

“…YY1 can increase Snail expression by binding to its 3 0 enhancer in melanoma cells (25). It has been indicated that silencing of YY1 disrupts the hypoxia-induced HIF1a stability and significantly suppressed growth of metastatic cancer cells (26). Significantly, previous studies have established that YY1 can interplay with P300 and CBP, as well as HDAC1, 2, 3 to recruit HDACs to repress gene transcription (27,28).…”

Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2′-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles

“…Similar trend has been observed with intravenous injection of the same cell line into the lungs of SCID mice. 25 The decrease or plateau phase could be partially attributable to the tissue attenuation of bioluminescence signal rising from the deep tissue, resulting in unproportional increase of signal with the tumor growth. As shown in Figure 3 (lower panel), day 7 and day 14 had increasing PET SUV but similar bioluminescence signal likely due to tissue attenuation in BLI on day 14.…”

New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer

“…6). Moreover, it has been shown that YY1 is a negative regulator of p53 protein, and a positive regulator of HIF1a given that its inhibition reduces the accumulation and the activity of HIF1a under hypoxic condition (184). Such an observation suggests the involvement of HDAC-induced repressor activity of YY1 in cancer metabolic switch.…”